drugset / Trial / NCT05951465
Esketamine and Propofol for Children With Autism Spectrum Disorder Undergoing Colonoscopy
Completed
46 enrolled
The Second Hospital of Nanjing Medical University
Nanjing Medical University · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to examine the dose-response relationship of esketamine in combination with propofol for children with Autism Spectrum Disorder undering colonoscopy.
Timeline
- Start
- 2023-07-20
- Primary completion
- 2023-09-20
- Completion
- 2023-09-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esketamine | Other / unclassified | 0.3 mg/kg | — |
| Subject | Esketamine | Other / unclassified | 0.6 mg/kg | — |
| Subject | Propofol | Small molecule | 2 mg/kg | — |
| Subject | Propofol | Small molecule | 2.5 mg/kg | — |